FindTrial
Sign In

Technical prevention and treatment of multidrug-resistant bacterial infection in ICU

Technical prevention and treatment of multidrug-resistant bacterial infection in ICU

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052206
Enrollment
Unknown
Registered
2021-10-22
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple drug-resistant bacterial infections in ICU

Interventions

Tigecycline group:None
Colistin group:None
Carbapenem group:None
Sulperazone group:None

Sponsors

Shandong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 years; 2. Critically ill patients who stay in the ICU for more than 24 hours.

Exclusion criteria

Exclusion criteria: Lactation or pregnancy.

Design outcomes

Primary

MeasureTime frame
hospital stay;in-hospital mortality;—

Countries

China

Contacts

Public ContactWang Peng

Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine

15168887139@163.com+86 15168860931

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026